Catalent Micron

Catalent Micron Technologies is a contract provider of pharmaceutical particle-size reduction, specializing in air-jet-milling micronization and analytical services. Catalent acquired the business in 2014, adding it to its drug-delivery offerings. Its 84,000-square-foot Malvern cGMP facility helps solve bioavailability challenges, improve content uniformity, and produce the fine particle sizes required for inhaled drugs, at both R&D and commercial scale. Catalent was taken private by Novo Holdings in December 2024.